O-I Glass, Inc., through its subsidiaries, manufactures and sells glass containers to food and beverage manufacturers primarily in the Americas, Europe, and the Asia Pacific. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.

Michael Joseph

O-I Glass, Inc.

Glass Health

Glass Health is thrilled to announce our $5M seed round led by Initialized Capital. 🎉

Our latest funding will further our mission to empower clinicians with generative AI for clinical decision support.

We’re proud to count prominent healthcare founders as mentors and investors in this seed round, including Tom Lee, founder of One Medical, Epocrates, and Galileo Health; Connor Landgraf, founder of Eko Health; and Heather Hasson & Trina Spear, the co-founders of FIGS.

https://lnkd.in/gfA9xW6w

#Y Combinator #Breyer Capital #Initialized Capital

Our Glass AI CDS platform has been upgraded with a new core feature...🥁🎁

Glass Consult is our NEW clinical reference chatbot✨

Consult uses physician-validated context to answer clinical reference questions with in-text references at glass.health🎊🦾

Check out Glass Consult in action above, featuring physician-validated context on Acute Appendicitis by Glass Health AI Clinical Fellows & AI Editors, Marianne Ruelle, MD; Deven Patel, MD; & Gurbani Kaur, MD

#AI #AICDS #healthcareinnovation #healthcaretechnology #aiinhealthcare 

Y Combinator Initialized Capital

Tomorrow is almost here...

#healthcareinnovation #ai #healthcare #healthcaretechnology #AICDS

Introducing History & Physical Mode! 

Clinicians, we heard your request for better handling of complex cases by Glass AI. Starting today, you can input a full H&P to draft AI-assisted differential diagnoses and clinical plans. 

Try H&P Mode now at http://glass.health

This update includes major upgrades to the Glass user interface and its ability to assist with differential diagnosis and clinical plan drafting. Clinical training of Glass AI is ongoing by the Glass Health team of academic clinical contributors.

Glass AI is an experimental product in development. Given ongoing development and LLM limitations, all AI results should be supervised at the level of a trainee, interpreted cautiously, and should never replace clinician knowledge or judgment.

#healthcareinnovation #ai #aiinhealthcare Y Combinator

Glass Health's mission to empower clinicians with AI-assisted diagnosis and clinical decision-making is featured in this recent piece by the World Economic Forum 🏥 

https://lnkd.in/ehQa48Mk

🎊 New Updates to Glass AI🎊

The Glass Health team has trained Glass AI to draft clinical plans for new topics!

Check out our new handling of...
- hypoxemia
- hemoptysis
- community-acquired PNA

We're also sharpening Glass AI's ability to develop a DDx for high-yield medicine topics, including:

- hypoxemia
- constipation
- TIA
- UTI.

Just try entering a one-liner at http://glass.health. Glass AI will suggest 5 potential diagnoses to consider.

#ai #healthcare #healthtech #medicine Y Combinator Dereck Paul, MD Graham Ramsey

🚨 NEW Version of Glass AI Available 🚨 

Glass AI 2.0 combines an LLM with a clinical knowledge database created by our clinician team.

With clinician training, we create better DDx and Clinical Plan outputs than base LLMs.

Try 2.0 now at http://glass.health/ai

Clinicians have trained Glass AI 2.0 for this first release on a select group of high-yield medical topics.

Training is ongoing and you can view the full list of medical topics included in this release within the product.

Glass AI is in development to assist clinicians with differential diagnosis, evidence-based Tx, and documentation.

We make advances with your feedback and thank the community who has used Glass AI 1.0 over the past few weeks.

Please remember, Glass AI is a reference tool and assistant, like a smart textbook. It does not replace clinician judgment and should always be supervised.

Notably, Glass AI was not created for the general public and does not generate general advice medical advice.

Today's release of Glass AI 2.0 is the collective effort of the incredible Glass AI Clinical Contributor team. Full credits within the Glass AI tab in the Glass platform.

cc: Dereck Paul, MD, Graham Ramsey, Y Combinator, Breyer Capital

Metric
Company Name	O-I Glass, Inc.
Symbol	OI
MSH ID	COM:O-I
Market	STOCKS
Sector	Consumer Cyclical
Industry	Packaging & Containers
Country	US
Stage
Employee Count	23K
Website	o-i.com
LinkedIn
Founders

Metric
Market Cap	1.64B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	7.11B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.50B
EBITDA	864M
Operating Income	864M
Net Income	219M
EPS	1.42
Diluted EPS	1.42
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.20
Operating Profit Margin	0.12
EBITDA Margin	0.12
Net Profit Margin	-0.01
Return on Equity	-0.05
Return on Assets	-0.01
Return on Capital Employed	0.11

COM:O-I

Glass Health

Last Close

12.85

22/11 21:00

Market Cap

1.64B

Beta: -

Volume Today

974.14K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	5.94
P/B Ratio	1.07
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.34
EV Multiple	-1.44

Metric
Days Sales Outstanding	39.07
Days Payables Outstanding	80.98
Days Inventory Outstanding	79.06
Operating Cycle	121.64
Cash Conversion Cycle	45.19
Asset Turnover	0.73

Metric
Operating Cash Flow	796M
Free Cash Flow	108M
Cash Flow to Debt	0.20
Operating Cash Flow/Sales	0.15
Free Cash Flow Yield	0.07

Metric
Cash & Equivalents	913M
Accounts Receivable	151M
Inventory	1.07B
Goodwill	1.47B
Debt to Capitalization	0.77
Debt to Assets	0.50
Current Ratio	1.40
Quick Ratio	0.75

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue	0.01
SG&A to Revenue